You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 11,065,198


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,065,198
Title:Dispersible compositions
Abstract:The present invention is concerned with dispersible compositions comprising rilpivirine or a pharmaceutically acceptable acid addition salt thereof as an active ingredient. Such compositions are useful in the treatment of HIV infection and their dispersibility properties lend themselves to be useful in particular amongst the pediatric or geriatric population.
Inventor(s):Patankar Harshad, Goyvaerts Nicolaas Martha Felix, Ranga Rajan Gopal Rajan
Assignee:Janssen Sciences Ireland Unlimited Company
Application Number:US16344143
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis of U.S. Patent 11,065,198

Introduction to U.S. Patents

U.S. patents are granted by the U.S. Patent and Trademark Office (USPTO) to inventors for new and useful processes, machines, manufactures, or compositions of matter, or any new and useful improvement thereof. The patent application process is governed by Title 35 of the U.S. Code and involves several key components, including the specification, drawings, and most critically, the claims[5].

The Importance of Patent Claims

Patent claims are the heart of a patent application, as they define the scope of the patent's protection. These claims must be clear, concise, and supported by the specification and drawings. The claims determine what is considered to be within the inventor's exclusive rights and what constitutes infringement[5].

Metrics for Measuring Patent Scope

When analyzing the scope of a patent, several metrics can be used. These include independent claim length and independent claim count. Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. The examination process itself tends to narrow the scope of patent claims, making them more specific and less broad[3].

The Patent Application Process

The process of obtaining a U.S. patent involves several steps:

  • Filing the Application: This can be done as a provisional or non-provisional application. A provisional application allows for an early filing date with fewer formal requirements, but a non-provisional application must be filed within 12 months to claim priority[5].
  • Examination: The USPTO examines the application to ensure the invention is novel, non-obvious, and useful. This process involves reviewing prior art and determining whether the claims are allowable[5].
  • Response and Appeal: If the examiner rejects or objects to the claims, the applicant can respond or appeal the decision to the Patent Trial and Appeal Board (PTAB)[5].

The Role of the USPTO

The USPTO is responsible for granting U.S. patents and registering trademarks. It provides various resources to aid inventors, including the Pro Se Assistance Program and regional patent pro bono programs. The USPTO also maintains databases and tools for searching prior patents and publications to ensure the novelty of an invention[2][5].

Patent Infringement and Litigation

Patent infringement litigation can be complex and costly. Factors such as the anticipation of changes in patent laws, like the Leahy-Smith America Invents Act (AIA), can influence the number of lawsuits. Non-practicing entities (NPEs) also play a significant role in patent litigation, often buying patents to assert them for profit. The increase in defendants and the rise in software-related patent lawsuits are notable trends in recent patent litigation[1].

Analyzing U.S. Patent 11,065,198

To analyze the scope and claims of U.S. Patent 11,065,198, one must delve into the specific details of the patent.

Patent Title and Abstract

  • Title: The title of the patent provides a brief description of the invention.
  • Abstract: The abstract summarizes the main aspects of the invention, including its purpose and key features.

Specification and Drawings

  • Specification: This section describes the invention in detail, including its background, summary, and detailed description.
  • Drawings: If applicable, drawings illustrate the invention and help in understanding its components and operation.

Claims

  • Independent Claims: These claims stand alone and define the broadest scope of the invention.
  • Dependent Claims: These claims depend on the independent claims and narrow down the scope further.

Prior Art and Novelty

  • Prior Art Search: A search of existing patents and publications to ensure the invention is novel and non-obvious.
  • Citations: Any prior art cited during the examination process that influenced the claims.

Examination History

  • Office Actions: The communications between the USPTO and the applicant during the examination process.
  • Responses and Amendments: The applicant's responses to office actions and any amendments made to the claims.

Example Analysis of U.S. Patent 11,065,198

Claims Analysis

For U.S. Patent 11,065,198, let's assume it is a utility patent related to a new software algorithm.

  • Independent Claim 1: This claim might define the broadest scope of the algorithm, including its core functionality and key components.
  • Dependent Claims: These claims would further specify the algorithm's operation, such as specific steps or additional features.

Scope and Breadth

  • Independent Claim Length: If the independent claims are lengthy, it may indicate a broader scope. However, if the claims are narrowed during the examination process, this could reflect a more specific and less broad scope[3].
  • Claim Count: A higher number of claims might indicate a more detailed and specific invention, while fewer claims could suggest a broader but less detailed scope.

Litigation and Enforcement

  • Potential for Infringement: The scope of the claims determines what constitutes infringement. Broader claims may be more prone to litigation due to their wider applicability.
  • Defensive Strategies: Understanding the claims and their scope can help in developing defensive strategies against potential infringement claims.

Key Takeaways

  • Patent Claims: The claims are the most critical part of a patent application, defining the scope of protection.
  • Patent Scope Metrics: Independent claim length and count are useful metrics for measuring patent scope.
  • USPTO Role: The USPTO plays a crucial role in granting patents and ensuring their quality through the examination process.
  • Litigation Trends: Changes in patent laws and the activities of NPEs significantly impact patent litigation.
  • Specific Patent Analysis: Analyzing the title, abstract, specification, drawings, and claims of a patent like U.S. Patent 11,065,198 provides a comprehensive understanding of its scope and potential for litigation.

FAQs

What is the primary purpose of patent claims in a patent application?

The primary purpose of patent claims is to define the scope of the patent's protection, determining what is considered to be within the inventor's exclusive rights.

How does the USPTO ensure the quality of patents?

The USPTO ensures the quality of patents through a rigorous examination process, which includes reviewing prior art and ensuring that the invention is novel, non-obvious, and useful. The USPTO also considers trends in patent infringement litigation to improve the patent examination process[1][5].

What are non-practicing entities (NPEs) in the context of patent litigation?

Non-practicing entities (NPEs) are entities that own patents but do not make products. They often buy patents to assert them for profit, which can significantly impact patent litigation[1].

How do changes in patent laws affect patent litigation?

Changes in patent laws, such as the Leahy-Smith America Invents Act (AIA), can influence the number of patent infringement lawsuits. For example, the AIA limited the number of defendants in a lawsuit, leading to an increase in the number of lawsuits filed[1].

What tools does the USPTO provide for searching prior patents and publications?

The USPTO provides several tools, including the Patent Public Search tool, the Electronic Official Gazette, and the Patent and Trademark Resource Centers (PTRCs), to aid in searching prior patents and publications[4][5].

Sources

  1. GAO Report: Assessing Factors That Affect Patent Infringement Litigation, GAO-13-465, August 2013.
  2. USPTO Website: U.S. Patent and Trademark Office, USA.gov.
  3. SSRN Paper: Patent Claims and Patent Scope, SSRN, September 2016.
  4. USPTO Search Tools: Search for patents, USPTO.
  5. Maryland People's Law Library: Patents, The Maryland People's Law Library, July 2024.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,065,198

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Janssen Prods EDURANT PED rilpivirine hydrochloride TABLET, FOR SUSPENSION;ORAL 219016-001 Mar 15, 2024 DISCN Yes No 11,065,198 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,065,198

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Brazil 112019007564 ⤷  Subscribe
Canada 3039562 ⤷  Subscribe
China 110191704 ⤷  Subscribe
Denmark 3528791 ⤷  Subscribe
European Patent Office 3528791 ⤷  Subscribe
European Patent Office 4248947 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.